Supernus Pharmaceuticals (SUPN)
(Real Time Quote from BATS)
$29.93 USD
-0.02 (-0.07%)
Updated Apr 24, 2024 09:44 AM ET
5-Strong Sell of 5 5
D Value D Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | 0.39 |
EPS Last Quarter | 0.02 |
Last EPS Surprise | -95.12% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 1.64 |
Next Year | 1.95 |
EPS (TTM) | 0.00 |
P/E (F1) | 18.30 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 146.44M | 150.06M | 601.95M | 609.61M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 151.90M | 153.07M | 609.85M | 661.70M |
Low Estimate | 143.60M | 148.10M | 594.10M | 582.02M |
Year ago Sales | 153.76M | 135.56M | 607.52M | 601.95M |
Year over Year Growth Est. | -4.76% | 10.69% | -0.92% | 1.27% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.39 | 0.38 | 1.64 | 1.95 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.48 | 0.40 | 1.80 | 2.55 |
Low Estimate | 0.29 | 0.35 | 1.53 | 1.04 |
Year ago EPS | 0.29 | -0.02 | 0.02 | 1.64 |
Year over Year Growth Est. | 34.48% | 2,000.00% | 8,100.00% | 18.90% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.39 | 0.38 | 1.64 | 1.95 |
7 Days Ago | 0.39 | 0.38 | 1.64 | 1.95 |
30 Days Ago | 0.39 | 0.38 | 1.64 | 1.95 |
60 Days Ago | 0.40 | 0.44 | 1.80 | 2.12 |
90 Days Ago | 0.41 | 0.45 | 1.92 | 2.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.39 | 0.38 | 1.64 | 1.95 |
Zacks Consensus Estimate | 0.39 | 0.38 | 1.64 | 1.95 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.02 | -0.29 | -0.02 | 0.29 | NA |
Estimate | 0.41 | 0.13 | 0.23 | 0.12 | NA |
Difference | -0.39 | -0.42 | -0.25 | 0.17 | -0.22 |
Surprise | -95.12% | -323.08% | -108.70% | 141.67% | -96.31% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more